Standout Papers
Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Estimating the Impact of the Hajj: Religion and Tolerance in Islam's Global Gathering *
2009 StandoutNobel
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report.
2006
Age of entry to day nursery and allergy in later childhood
1999
Comparison of two commercial interferon-γ assays for diagnosingMycobacterium tuberculosisinfection
2006
Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy
2007
Why Don't Physicians Follow Clinical Practice Guidelines?
1999 Standout
Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection
1993
The Tuberculin Skin Test
1993 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfections
2002 Standout
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Rheumatoid arthritis
2016 Standout
Regression of low-grade squamous intra-epithelial lesions in young women
2004
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Epidemiologic Evidence for Time Variation in HIV Infectivity
1998
Tuberculosis
2015
CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1
1997
Mycobacterial infection in a series of 1261 renal transplant recipients
2003
Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital
2001
Nosocomial Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Spain
1996
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
2011
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children
2006
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Global Burden of Tuberculosis
1999 Standout
Screening for Tuberculosis Infection Using Whole-Blood Interferon-γ and Mantoux Testing Among Japanese Healthcare Workers
2006
Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females
2001
The Regulation of Sulfur Metabolism in Mycobacterium tuberculosis
2011 StandoutNobel
Use of the T-SPOT.TB Assay to Detect Latent Tuberculosis Infection Among Rheumatic Disease Patients on Immunosuppressive Therapy
2009
Tuberculosis Testing
1996
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
Low Sensitivity of a Whole‐Blood Interferon‐γ Release Assay for Detection of Active Tuberculosis
2006
Human papillomavirus and cervical cancer
2007 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Improved Outcomes for Patients with Multidrug-Resistant Tuberculosis
1995
Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
2009
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
2007
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
1993 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
A Comparison of Outbreak‐ and Nonoutbreak‐Related Multidrug‐Resistant Tuberculosis Among Human Immunodeficiency Virus–Infected Patients in a South African Hospital
1999
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Rheumatoid arthritis
2010 Standout
Mycobacterial and Other Serious Infections in Patients Receiving Anti–Tumor Necrosis Factor and Other Newly Approved Biologic Therapies: Case Finding through the Emerging Infections Network
2008
The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular Methods
1994
Tests for Latent Tuberculosis in People With ESRD: A Systematic Review
2012
Regulation of type I interferon responses
2013 Standout
Transmission of Multidrug-Resistant Mycobacterium tuberculosis among Persons with Human Immunodeficiency Virus Infection in an Urban Hospital: Epidemiologic and Restriction Fragment Length Polymorphism Analysis
1993
Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors
2008
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
2006
The Clinical Presentation of Tuberculosis
1998
Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey
2001 Standout
Recent Advances in Pulmonary Medicine
1993
Treatment of Multidrug-Resistant Tuberculosis
1993
Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India
2006
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Molecular Fingerprinting ofMycobacterium tuberculosis: How Can It Help the Clinician?
1997
Health risks at the Hajj
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
2006 Standout
Chronic Kidney Disease
2016 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Staphylococcus aureusInfections
1998 Standout
The biological cost of antimicrobial resistance
1997
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Comorbidities in rheumatoid arthritis
2007
Silicosis
2012 Standout
Pulmonary tuberculosis case detection through fortuitous cough screening during home visits
2009
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Specific Detection of Tuberculosis Infection
2004
An Update on the Diagnosis of Tuberculosis Infection
2006
Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay
2006
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
2007
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Transmission of Mycobacterium tuberculosis by a Fiberoptic Bronchoscope
1997
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
2007 Standout
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
Transmission of a Highly Drug-Resistant Strain (Strain W1) of Mycobacterium tuberculosis
1997
Impact of a 16-Community Trial to Promote Judicious Antibiotic Use in Massachusetts
2007
Efficacy of BCG Vaccine in the Prevention of Tuberculosis
1994 Standout
Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
2007
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
A Paper-Based Multiplexed Transaminase Test for Low-Cost, Point-of-Care Liver Function Testing
2012
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Reducing Antibiotic Use in Children: A Randomized Trial in 12 Practices
2001
The Immune Response in Tuberculosis
2013 Standout
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
1997 Standout
Understanding Latent Tuberculosis: A Moving Target
2010
Multidrug-resistantMycobacterium tuberculosisin HIV-Infected Persons, Peru
2003
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
An overview of nosocomial infections, including the role of the microbiology laboratory
1993
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Works of John Jereb being referenced
Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008.
2010
Tuberculosis associated with therapy against tumor necrosis factor α
2005
National Survey to Measure Rates of Liver Injury, Hospitalization, and Death Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection
2005
Comparison of Sensitivities to Two Commercially Available Tuberculin Skin Test Reagents in Persons with Recent Tuberculosis
1997
Resurgence of tuberculosis in children
1992 Standout
Nosocomial Transmission of Multidrug-resistant Mycobacterium tuberculosis
1992
Nosocomial Outbreak of Tuberculosis in a Renal Transplant Unit: Application of a New Technique for Restriction Fragment Length Polymorphism Analysis of Mycobacterium tuberculosis Isolates
1993
Severe or Fatal Liver Injury in 50 Patients in the United States Taking Rifampin and Pyrazinamide for Latent Tuberculosis Infection
2006
Antituberculosis Drugs and Hepatotoxicity
2007
An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy
2006
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
2005
Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999.
2003
Respiratory infections in day care.
1994
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
2010
A MODEL FOR INTERVAL‐CENSORED TUBERCULOSIS OUTBREAK DATA
1997
Progressing toward tuberculosis elimination in low-incidence areas of the United States. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
2002
Tuberculosis in Health Care Workers at a Hospital With an Outbreak of Multidrug-Resistant Mycobacterium tuberculosis
1995
Respiratory Infections in Day Care
1994